Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

SurModics acquires InnoRx

Executive Summary

Drug delivery company SurModics has acquired the 80% of privately held ophthalmic drug delivery firm InnoRx that it did not already own. The total consideration is $21.8mm, consisting of $4.1mm in cash and about 600k shares of SurModics' common stock (presently trading at $29.45 each), and includes earn-outs of an additional 600k common shares based on development and commercial milestones.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Includes Contract
    • Partial Acquisition
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies